
ProjectIdentify molecules to counteract STARD3 in HER2+ tumor cells
About
STARD3 is a sterol transporter located at the interface between the endoplasmic reticulum and endosomes. Interestingly, and as yet unexplained, STARD3 represents a genetic vulnerability for the HER2-type breast cancers+, particularly those resistant to anti-HER2 therapy. In other words, the proliferation of cells that become cancerous following the amplification of HER2 expression is uniquely linked to STARD3 activity. A body of evidence suggests that blocking the transport activity of STARD3 could provide a promising strategy against HER2-type cancers.+. Through approaches in vitro, We aim to select, test, and optimize compounds capable of interfering with STARD3 transport activity in order to identify molecules with anticancer potential and ultimately develop an effective therapeutic strategy centered on STARD3 – in collaboration with Dr. Catherine Tomasseto (IGBMC, Illkirch) and Dr. Jean-Michel Brunel (IJM, Marseille)











